Navigation Links
Skinvisible Signs Marketing Agreement for India
Date:12/6/2007

Avani to Represent Dermatology Products Featuring Invisicare(R)

LAS VEGAS, Dec. 6 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI) / (Website: http://www.skinvisible.com), is pleased to announce that it has signed a marketing agreement with Avani International for India. This follows Skinvisible's recent announcement that it was granted a comprehensive patent in India for Skinvisible's proprietary polymer delivery system, Invisicare. Invisicare enhances the delivery of topical dermatology products on the skin.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)

The agreement with Avani is part of Skinvisible's continued strategy to quickly expand its reach around the globe. Avani will seek licenses in India for topical products Skinvisible has developed for the treatment of acne, fungal infections, atopic dermatitis and hand sanitizers. They will also facilitate clinical studies and manufacturing in India.

"It is important for Skinvisible to develop partnerships with companies such as Avani as they have established relationships with pharmaceutical and consumer goods companies in India. This helps us fast track our marketing efforts in the country and generate license fees and royalties quicker than marketing in India ourselves," said Mr. Terry Howlett, President and CEO of Skinvisible Inc.

"India and its expanding population of over 1 billion people offers tremendous market opportunities for Skinvisible and its Invisicare technology and products," said Ash Chawla, Chairman & CEO of Avani. "This agreement allows us to introduce Invisicare to Indian pharmaceutical manufacturers that we know need this technology."

About Invisicare(R)

Skinvisible has patented its technology and trademarked its polymer delivery system Invisicare(R). Invisicare is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time. They are non-occlusive and allow normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. See: http://www.Invisicare.com

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare(R) to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. See: http://www.skinvisible.com

About Avani International

Avani International is a leading business development firm, with services ranging from product commercialization to launch, marketing, sales, and distribution for pharmaceutical, biotechnology and medical device industries. Avani enjoys strong relationships with manufacturers in India and has pioneered relations and business growth between US and Indian companies for the past five years. See: http://www.avaniinternational.com

Forward-Looking Statements

This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending September 30, 2007)

Corporate Contact:

Terry Howlett, President/CEO

Skinvisible Pharmaceuticals, Inc.

Phone: 702-433-7154

Email: info@skinvisible.com


'/>"/>
SOURCE Skinvisible, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
2. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
3. Pot bellies linked to early signs of cardiovascular disease
4. MSU engineering team designs innovative medical device
5. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
6. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
7. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
8. A new technology for cancer screening listens for the signs of cancer
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
11. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... , ... More than half of Americans suffering from noise-induced hearing loss do ... that causes hearing loss? May 1 marks the beginning of Better Hearing & Speech ... well as schedule a hearing evaluation for anyone with concerns about his/her hearing. , ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... (The National Campaign) announces its support for the Access to Contraception for Women ... Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ensure that all ...
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider of ... which enables sleep physicians to create and edit their interpretation reports. This solution ... a familiar interface that does not require additional training to use. It also ...
(Date:4/28/2017)... ... ... affects much more than energy – it also has mental and physical benefits. According to ... time, which can increase the risk of having a car accident. , This week ... to help you sleep better and feel better:, , Turn off ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces ... an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start ... 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and maintenance ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
Breaking Medicine Technology: